These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Freda BJ; Slawsky M; Mallidi J; Braden GL Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726 [TBL] [Abstract][Full Text] [Related]
3. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis. Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181 [TBL] [Abstract][Full Text] [Related]
4. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure. Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566 [TBL] [Abstract][Full Text] [Related]
5. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
6. Diuretics and ultrafiltration in acute decompensated heart failure. Felker GM; Mentz RJ J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934 [TBL] [Abstract][Full Text] [Related]
7. Diuretic Resistance in Acute Decompensated Heart Failure: A Challenging Clinical Conundrum. Reed BN; Devabhakthuni S Crit Care Nurs Q; 2017; 40(4):363-373. PubMed ID: 28834858 [TBL] [Abstract][Full Text] [Related]
8. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. Martin FL; Chen HH; Cataliotti A; Burnett JC Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the Combination of In-Hospital Poor Diuretic Response and Systemic Congestion to Predict Future Cardiac Events in Patients With Acute Decompensated Heart Failure. Aoki S; Okumura T; Sawamura A; Kitagawa K; Morimoto R; Sakakibara M; Murohara T Am J Cardiol; 2017 Jun; 119(12):2010-2016. PubMed ID: 28438307 [TBL] [Abstract][Full Text] [Related]
19. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure. Steuber TD; Janzen KM; Howard ML Pharmacotherapy; 2020 Sep; 40(9):924-935. PubMed ID: 32639593 [TBL] [Abstract][Full Text] [Related]
20. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure. Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]